Unknown

Dataset Information

0

Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis.

ABSTRACT:

SUBMITTER: Kunutsor SK 

PROVIDER: S-EPMC7255758 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19.
| S-EPMC7361465 | biostudies-literature
Unknown Systematic Review and Meta-Analysis of Sex-Specific COVID-19 Clinical Outcomes.
| S-EPMC7331754 | biostudies-literature
Unknown Prevalence and clinical outcomes of cardiac injury in patients with COVID-19: A systematic review and meta-analysis.
| S-EPMC7485447 | biostudies-literature
Unknown Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis.
| S-EPMC7658622 | biostudies-literature
Unknown The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan.
| S-EPMC7404742 | biostudies-literature
Unknown Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis.
| S-EPMC7566821 | biostudies-literature
Unknown Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis.
| S-EPMC7386238 | biostudies-literature
Unknown The Association of Metabolic-Associated Fatty Liver Disease with Clinical Outcomes of COVID-19: A Systematic Review and Meta-Analysis.
| S-EPMC9311786 | biostudies-literature
Unknown Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: A comprehensive systematic review and meta-analysis.
| S-EPMC8011308 | biostudies-literature
Unknown Cardiovascular drugs and COVID-19 clinical outcomes: A living systematic review and meta-analysis.
| S-EPMC8239929 | biostudies-literature